Evidence-Based Medicine Guidelines
Bisphosphonates in multiple myeloma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bisphosphonates in Multiple Myeloma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453621/all/Bisphosphonates_in_multiple_myeloma.
Bisphosphonates in multiple myeloma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453621/all/Bisphosphonates_in_multiple_myeloma. Accessed October 8, 2024.
Bisphosphonates in multiple myeloma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453621/all/Bisphosphonates_in_multiple_myeloma
Bisphosphonates in Multiple Myeloma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453621/all/Bisphosphonates_in_multiple_myeloma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bisphosphonates in multiple myeloma
ID - 453621
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453621/all/Bisphosphonates_in_multiple_myeloma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
